Research Progress on the Association Between DNA Topoisomerase IIα (TOP2A) and Malignant Tumors
International Journal of Medical Innovation · 15.05.2026 · 1 (1) · 58-62
DOI: 10.66128/ijmi202601.7 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Medical Innovation, online erschienen am 15.05.2026. Verfasst von Jing Shang und 4 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
DNA topoisomerase II alpha (TOP2A) is a key enzyme in eukaryotic cells and a key enzyme in regulating the cell cycle. In recent years, research has confirmed that TOP2A is mainly characterized by high expression in various malignant tumors, and its expression is closely related to tumor occurrence and development, invasion and metastasis, clinical staging, and patient prognosis. It is also an important target of classical chemotherapy drugs.
Zitieren
APA
Shang, J., Xie, Y., Liu, Y., Hu, Y., & Huang, X. (2026). Research Progress on the Association Between DNA Topoisomerase IIα (TOP2A) and Malignant Tumors. International Journal of Medical Innovation, 1(1), 58-62. https://doi.org/10.66128/ijmi202601.7
Vancouver
Shang J, Xie Y, Liu Y, Hu Y, Huang X. Research Progress on the Association Between DNA Topoisomerase IIα (TOP2A) and Malignant Tumors. International Journal of Medical Innovation. 2026;1(1):58-62. doi:10.66128/ijmi202601.7
BibTeX
@article{Shang2026,
author = {Shang, Jing and Xie, Yao and Liu, Ying and Hu, Yansong and Huang, Xuejing},
title = {Research Progress on the Association Between DNA Topoisomerase IIα (TOP2A) and Malignant Tumors},
journal = {International Journal of Medical Innovation},
year = {2026},
volume = {1},
number = {1},
pages = {58--62},
doi = {10.66128/ijmi202601.7}
}
EUVIMED